Healthcare Sector

SANA

Market Tracker

$2.56
+0.02
(+0.79%)
8:20 am
Next Earnings: (est.) 08/05/23 12:00 am
  • SANA (Selected)

    Sana Biotechnology, Inc.

SANA Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

SANA Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

SANA Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

SANA Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

SANA Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

SANA Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/18/2025 CALL $5.00 2,692 +480 +21.70%
06/20/2025 CALL $2.50 837 +444 +112.98%
07/18/2025 CALL $2.50 1,983 +150 +8.18%
01/16/2026 CALL $2.00 547 +132 +31.81%
01/16/2026 CALL $5.00 2,906 +77 +2.72%
01/16/2026 PUT $2.50 495 +50 +11.24%
06/20/2025 CALL $7.50 1 0
06/20/2025 PUT $2.50 66 0
06/20/2025 PUT $5.00 0 0
06/20/2025 PUT $7.50 0 0
07/18/2025 PUT $7.50 0 -1 -100.00%
01/16/2026 PUT $1.50 146 -2 -1.35%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

SANA Major Holders

Name Pct Held Shares Total
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 2.27% 4.34M 27.06M
Vanguard Total Stock Market Index Fund 1.55% 2.97M 18.49M
Vanguard U.S. Growth Fund 1.28% 2.46M 15.3M
Vanguard Small-Cap Index Fund 1.28% 2.45M 15.29M
iShares Russell 2000 ETF 1.02% 1.95M 12.15M
Price (T.Rowe) New Horizons Fund 0.89% 1.71M 10.64M
Price (T.Rowe) Health Sciences Fund 0.84% 1.61M 10.02M
Vanguard Small-Cap Growth Index Fund 0.74% 1.42M 8.82M
Vanguard Extended Market Index Fund 0.63% 1.2M 7.46M
iShares Russell 2000 Value ETF 0.46% 886.99k 5.53M

SANA News

  • SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    05/19 10:22 am

    Benzinga

    Read more
  • INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

    05/14 02:50 pm

    GlobeNewswire Inc.

    Read more
  • SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    05/12 09:50 am

    Benzinga

    Read more
  • Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA

    05/11 09:40 am

    GlobeNewswire Inc.

    Read more
  • SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    05/04 04:00 pm

    GlobeNewswire Inc.

    Read more
  • SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    04/29 09:30 am

    Benzinga

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

    04/29 08:00 am

    GlobeNewswire Inc.

    Read more
  • EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    04/27 04:00 pm

    GlobeNewswire Inc.

    Read more
  • SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    04/27 04:00 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

    04/27 01:57 pm

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

    04/26 10:42 am

    GlobeNewswire Inc.

    Read more
  • SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    04/24 10:32 am

    Benzinga

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA

    04/21 11:00 am

    GlobeNewswire Inc.

    Read more
  • DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

    04/20 08:32 am

    GlobeNewswire Inc.

    Read more
  • ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM

    04/18 01:58 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

    04/18 01:38 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

    04/12 01:20 pm

    GlobeNewswire Inc.

    Read more
  • SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc.

    04/07 02:46 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

    04/05 10:35 pm

    GlobeNewswire Inc.

    Read more
  • ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA

    04/02 09:09 pm

    GlobeNewswire Inc.

    Read more
  • Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc. (SANA)

    03/31 01:01 pm

    GlobeNewswire Inc.

    Read more
  • SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

    03/30 04:00 pm

    GlobeNewswire Inc.

    Read more
  • CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain

    03/05 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology to Present at May and June 2024 Investor Conferences

    05/06 04:05 pm

    GlobeNewswire Inc.

    Read more
  • 4 Stocks to Keep a Tab on for Amazing Earnings Acceleration

    05/03 07:25 am

    Zacks Investment Research

    Read more
  • Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday

    03/04 11:40 am

    Benzinga

    Read more
  • Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    03/01 02:19 pm

    Benzinga

    Read more
  • Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

    03/01 12:18 pm

    Benzinga

    Read more
  • Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

    02/29 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference

    02/28 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

    02/13 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

    02/12 05:05 pm

    GlobeNewswire Inc.

    Read more
  • PayPal Reports Q4 Results, Joins Rapid7, GoPro And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

    02/08 05:49 am

    Benzinga

    Read more
  • Sana Biotechnology Announces Pricing of Upsized Public Offering

    02/08 02:22 am

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Announces Proposed Public Offering of Common Stock

    02/07 05:01 pm

    GlobeNewswire Inc.

    Read more
  • Are You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice

    01/18 01:00 pm

    Zacks Investment Research

    Read more
  • Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why

    01/18 11:24 am

    Zacks Investment Research

    Read more
  • Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday

    01/11 11:32 am

    Benzinga

    Read more
  • Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    01/10 02:06 pm

    Benzinga

    Read more
  • Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies

    01/05 10:00 am

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    01/03 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting

    12/11 10:00 am

    GlobeNewswire Inc.

    Read more
  • Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    12/04 02:10 pm

    Benzinga

    Read more
  • Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System

    12/01 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes

    11/17 10:00 am

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates

    11/08 05:05 pm

    GlobeNewswire Inc.

    Read more
  • Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting

    11/02 09:05 am

    GlobeNewswire Inc.

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023

    09/25 11:00 am

    Benzinga

    Read more
  • Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    09/13 02:07 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: